Elizabeth Donley is CEO of Stemina. Ms. Donley brings a unique combination of business and legal experience to Stemina. She has more than a dozen years of experience in intellectual property, law and business management. Ms. Donley served as General Counsel and Director of Business Development for WARF for more than eight years. During those eight years, Ms. Donley negotiated hundreds of license, sponsored research and collaboration agreements between industry and WARF, the intellectual property management organization for the University of Wisconsin. Ms. Donley also served as Managing Director of both WARF subsidiaries: WiSys Technology Foundation (WiSys) and WiCell Research Institute (WiCell). WiCell distributes human embryonic stem (HES) cells, trains researchers worldwide and conducts important research involving many aspects of HES cell research. In 2005, WiCell was awarded a $16 million contract by the National Institutes of Health to serve as the National Stem Cell Bank.

Prior to joining WARF in 1998, Ms. Donley practiced law with the law firm of Quarles & Brady in the areas of intellectual property law, business transactions, securities and corporate law. She holds a law degree from the University of Wisconsin Law School, an M.B.A. in finance from the UW-Whitewater and an M.S. in bacteriology from the UW-Madison.

Dr. Cezar is a member of Standard & Poor’s Society of Industry Leaders and serves on the scientific advisory board of stem cell technology and patient advocacy organizations. She is an internationally renowned invited speaker at numerous conferences.